Molecular Dynamics Simulation of SARS-CoV-2 E Ion Channel: The Study of Lone Protein and its Conformational Changes in Complex with Potential Cage Inhibitors
Vadim Andreevich Shiryaev, Elena Alexandrovna Ivleva, Maria Sergeevna Zaborskaya, Ilya Michailovich Tkachenko, Vitaly Alexandrovich Osyanin, Yuri Nikolaevich Klimochkin
{"title":"Molecular Dynamics Simulation of SARS-CoV-2 E Ion Channel: The Study of Lone Protein and its Conformational Changes in Complex with Potential Cage Inhibitors","authors":"Vadim Andreevich Shiryaev, Elena Alexandrovna Ivleva, Maria Sergeevna Zaborskaya, Ilya Michailovich Tkachenko, Vitaly Alexandrovich Osyanin, Yuri Nikolaevich Klimochkin","doi":"10.2174/0115734099247899240326073802","DOIUrl":null,"url":null,"abstract":"Background: The coronavirus E ion channel has previously been studied as a potential target for antiviral therapy, with several compounds found to bind to the channel. However, these compounds have low activity, searching for effective E ion channel inhibitors of great importance. Objective: This study aimed to develop a computational approach for designing ligands for the coronaviral E ion channel and identify potential inhibitors based on this approach. Methods: The structure of the E-ion channel was refined using molecular dynamics, and the pore responsible for binding cage compounds was selected as the inhibitor-binding site. Potential inhibitor structures were identified using molecular docking, and their binding was confirmed using molecular dynamics simulations. Results: A number of potential SARS E ion channel inhibitors have been identified, and the binding modes and possible mechanisms of action of these inhibitors have been clarified. Conclusion: This study presents a computational approach that can be used to design ligands for E ion channels and identify potential inhibitors, providing valuable insights into the development of new antiviral therapies. The behavior of the E protein pentamer of SARS-CoV-2 in its native environment was investigated using Molecular Dynamics (MD), resulting in an equilibrated structure that could be used to develop new inhibitors through molecular docking. Simulation of the MD of E-channel complexes with amantadine analogues allowed for the identification of the main types of ligand-protein interactions that are responsible for the good binding of ligands within the channel's inner chamber.","PeriodicalId":10886,"journal":{"name":"Current computer-aided drug design","volume":"118 1","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current computer-aided drug design","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115734099247899240326073802","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The coronavirus E ion channel has previously been studied as a potential target for antiviral therapy, with several compounds found to bind to the channel. However, these compounds have low activity, searching for effective E ion channel inhibitors of great importance. Objective: This study aimed to develop a computational approach for designing ligands for the coronaviral E ion channel and identify potential inhibitors based on this approach. Methods: The structure of the E-ion channel was refined using molecular dynamics, and the pore responsible for binding cage compounds was selected as the inhibitor-binding site. Potential inhibitor structures were identified using molecular docking, and their binding was confirmed using molecular dynamics simulations. Results: A number of potential SARS E ion channel inhibitors have been identified, and the binding modes and possible mechanisms of action of these inhibitors have been clarified. Conclusion: This study presents a computational approach that can be used to design ligands for E ion channels and identify potential inhibitors, providing valuable insights into the development of new antiviral therapies. The behavior of the E protein pentamer of SARS-CoV-2 in its native environment was investigated using Molecular Dynamics (MD), resulting in an equilibrated structure that could be used to develop new inhibitors through molecular docking. Simulation of the MD of E-channel complexes with amantadine analogues allowed for the identification of the main types of ligand-protein interactions that are responsible for the good binding of ligands within the channel's inner chamber.
背景:以前曾将冠状病毒 E 离子通道作为抗病毒治疗的潜在靶点进行过研究,发现了几种能与该通道结合的化合物。然而,这些化合物的活性很低,因此寻找有效的 E 离子通道抑制剂非常重要。研究目的本研究旨在开发一种设计冠状病毒 E 离子通道配体的计算方法,并在此基础上确定潜在的抑制剂。研究方法使用分子动力学方法完善 E 离子通道的结构,并选择负责结合笼状化合物的孔作为抑制剂结合位点。通过分子对接确定潜在的抑制剂结构,并通过分子动力学模拟确认其结合。结果:确定了一些潜在的 SARS E 离子通道抑制剂,并阐明了这些抑制剂的结合模式和可能的作用机制。结论这项研究提出了一种计算方法,可用于设计 E 离子通道的配体和鉴定潜在的抑制剂,为开发新的抗病毒疗法提供了宝贵的见解。利用分子动力学(MD)研究了 SARS-CoV-2 的 E 蛋白五聚体在其原生环境中的行为,得出了一个平衡结构,可用于通过分子对接开发新的抑制剂。通过模拟金刚烷胺类似物与 E 通道复合物的 MD,确定了配体与蛋白质相互作用的主要类型,这些相互作用是配体在通道内腔良好结合的原因。
期刊介绍:
Aims & Scope
Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.
Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews, original research articles and letter articles written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, theoretical chemistry; computational chemistry; computer and molecular graphics; molecular modeling; protein engineering; drug design; expert systems; general structure-property relationships; molecular dynamics; chemical database development and usage etc., providing excellent rationales for drug development.